Cubist Systematic Strategies »

Protalix Biotherapeutics shares owned by Cubist Systematic Strategies

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Cubist Systematic Strategies from 13F filings

Historical chart of Cubist Systematic Strategies investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Cubist Systematic Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Cubist Systematic Strategies

Quarter filed Position value Share count Share price at filing
2025-03-31 $137k 53k 2.56
2024-12-31 $55k 29k 1.88
2024-09-30 $24k 24k 1.02
2024-06-30 $38k 32k 1.17

More positions owned by Cubist Systematic Strategies

Spdr Gold Tr Gold Shs (GLD)
Oracle Corporation Call Option (ORCL)
Vaneck Etf Trust Gold Miners Etf Call Option (GDX)
Palantir Technologies Cl A Call Option (PLTR)
UnitedHealth Call Option (UNH)
Robinhood Mkts Com Cl A Call Option (HOOD)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Select Sector Spdr Tr Energy Call Option (XLE)
Nebius Group Shs Class A Call Option (NBIS)
Meta Platforms Cl A (META)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Netflix Call Option (NFLX)
Wal-Mart Stores (WMT)

View all positions for Cubist Systematic Strategies

Top funds holding Protalix Biotherapeutics

BlackRock
Opaleye Management
Renaissance Technologies
Northern Trust
Geode Capital Management
Stratos Wealth Partners
State Street Corporation
Vanguard Group
Morgan Stanley
Connor, Clark & Lunn Investment Management
UBS Group
Bridgeway Capital Management
Diametric Capital
Charles Schwab Investment Management
Commonwealth Equity Services

View all funds holding Protalix Biotherapeutics